JPRN-jRCT2031200141进行中（未招募）3 期
Effect of semaglutide on functional capacity in patients with type 2 diabetes and peripheral arterial disease(NN9535-4533) - STRIDE
Higo Yasumoto0 个研究点目标入组 800 人开始时间: 2020年10月9日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 800
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Male or female, age above or equal to 18 years at the time of informed consent (above or equal to 20 years for Japan)
- •-Diagnosed with type 2 diabetes
- •-Symptomatic PAD with intermittent claudication in Fontaine stage IIa
排除标准
- •-Treatment with GLP-1receptor agonist or DPP4 inhibitor
- •-Walking ability limited by condition other than PAD
- •-Planned orthopaedic surgery or other major surgery
- •-Vascular revascularisation procedure 180 days prior to screening or planned
研究者
相似试验
进行中（未招募）
1 期
A research study to compare a medicine called semaglutide against placebo in people with peripheral arterial disease and type 2 diabetesPeripheral arterial diseaseDiabetes Mellitus, Type 2MedDRA version: 21.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861EUCTR2019-003399-38-HUovo Nordisk A/S800
进行中（未招募）
1 期
A research study to compare a medicine called semaglutide against placebo in people with peripheral arterial disease and type 2 diabetesPeripheral arterial diseaseDiabetes Mellitus, Type 2MedDRA version: 21.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861EUCTR2019-003399-38-DKovo Nordisk A/S800
进行中（未招募）
3 期
A Research Study to Compare a Medicine Called Semaglutide Against Placebo in People With Peripheral Arterial Disease and Type 2 DiabetesCTRI/2022/04/042104ovo Nordisk AS33
进行中（未招募）
1 期
A research study to compare a medicine called semaglutide against placebo in people with peripheral arterial disease and type 2 diabetesEUCTR2019-003399-38-DEovo Nordisk A/S800
进行中（未招募）
1 期
A research study to compare a medicine called semaglutide against placebo in people with peripheral arterial disease and type 2 diabetesPeripheral arterial diseaseDiabetes Mellitus, Type 2MedDRA version: 21.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861EUCTR2019-003399-38-LVovo Nordisk A/S800